Erdogan-Trinkaus Ipek (CIK 2047026) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-12). Recent activity: Sell ETON (85 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | Eton Pharmaceuticals, Inc. (ETON) | Chief Commercial Officer | Sell | 85 | $1,436 |
Source: SEC Form 4 filings · as of 2025-12-12